The online survey platform, which counted Alphabet and Salesforce as investors, floated above its range while increasing the number of shares in the IPO.

Johnson & Johnson and AstraZeneca will get a chance to exit the orphan disease therapy developer, which has filed for an $86.3m IPO.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has completed a $122m initial public offering after underwriters exercised their greenshoe option.

The Novo-backed medical implant provider has filed to raise up to $97.8m in an initial public offering that comes after $103m in funding.

Karolinska Development has celebrated an exit as Umeå spinout Asarina Pharma went public in Sweden after raising $16.3m in its initial public offering.

The JD.com and Advance Publications-backed fashion e-commerce platform raised more than $670m while its investors sold $212m of shares.

Canopy Rivers, the corporate venturing unit spun out of cannabis grower Canopy Growth, has gone public through a reverse merger.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

The Rocket Internet-backed e-commerce platform is considering an initial public offering in the US early next year at a valuation of $1bn.

The immuno-oncology therapy developer's investors include UC’s office of the chief investment officer, which contributed to a $300m round in January.